Abstract
Vital organs such as the pancreas and the brain lack the capacity for effective regeneration. To overcome this limitation, an emerging strategy consists of converting resident tissue-specific cells into the cell types that are lost due to disease by a process called in vivo lineage reprogramming. Here we discuss recent breakthroughs in regenerating pancreatic β-cells and neurons from various cell types, and highlight fundamental challenges that need to be overcome for the translation of in vivo lineage reprogramming into therapy.
Original language | English |
---|---|
Pages (from-to) | 204-211 |
Number of pages | 8 |
Journal | Nature Cell Biology |
Volume | 17 |
Issue number | 3 |
DOIs | |
Publication status | Published - 27 Feb 2015 |